|
|
Marketing Authorisations
|
|
|
|
|
No therapeutic advance over probenecid
|
|
|
|
|
|
|
|
|
|
|
|
Different adverse effect profile from that of other anti-CMV drugs
|
|
|
|
|
|
|
|
|
|
Efficacy in healing corneal lesions, but no improvement in vision
|
|
|
|
|
|
|
|
|
|
An option for very troublesome eczema after failure of ciclosporin
|
|
|
|
|
|
|
|
|
|
A repurposed drug with no proven efficacy that can cause fatal thrombocytopenia
|
|
|
|
|
|
|
|
|
|
Reviews
|
|
|
|
|
Efficacy only demonstrated in chronic urticaria
|
|
|
|
|
|
|
|
|
|
Less pneumonia, but no proven effect on risk of hospital admission
|
|
|
|
|
|
|
|
|
|
|
|